Dr. Thomas Ichim is an accomplished biotech innovator with more than two decades of experience building and leading successful life science ventures. Widely recognized for his groundbreaking work in regenerative medicine and immunotherapy, he has held key leadership roles—including CEO, President, and Vice President—across both early-stage startups and major publicly traded companies. With a Ph.D. in Immunology, Dr. Ichim has made significant contributions to scientific research, publishing over 130 peer-reviewed papers and writing three textbooks.